On March 24, 25 and 26 MIAT has been inspected by the Italian Agency for Pharma (AIFA) in order to ascertain its eligibility to import and release APIs manufactured in extra EEU countries.
The controlled temperature warehouse and the refrigerated cell have been inspected and the various Standard Operating Procedures have been checked and verified.
No critical deficiency has been observed and for the limited major and minor deficiencies ascertained a report containing the evidence of the corrective actions will be sent to AIFA within end April.
